vs
Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and Innventure, Inc. (INV). Click either name above to swap in a different company.
Insight Molecular Diagnostics Inc. is the larger business by last-quarter revenue ($1.1M vs $822.0K, roughly 1.4× Innventure, Inc.). Insight Molecular Diagnostics Inc. runs the higher net margin — -2015.4% vs -4593.8%, a 2578.4% gap on every dollar of revenue. Insight Molecular Diagnostics Inc. produced more free cash flow last quarter ($-7.0M vs $-82.1M).
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Innventure, Inc. is a business development and commercialization firm that partners with large global corporations to turn their underutilized intellectual property and unused R&D innovations into scalable, high-growth independent businesses. It focuses on sectors including sustainability, advanced materials and life sciences, serving primarily North American and European markets.
IMDX vs INV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1M | $822.0K |
| Net Profit | $-23.0M | $-37.8M |
| Gross Margin | 42.5% | -1315.8% |
| Operating Margin | -2057.5% | -3859.1% |
| Net Margin | -2015.4% | -4593.8% |
| Revenue YoY | -23.4% | — |
| Net Profit YoY | 31.5% | — |
| EPS (diluted) | $-0.75 | $-0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1M | $822.0K | ||
| Q3 25 | $260.0K | $534.0K | ||
| Q2 25 | $518.0K | $476.0K | ||
| Q1 25 | $2.1M | $224.0K | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $115.0K | $317.0K | ||
| Q2 24 | $104.0K | — | ||
| Q1 24 | $176.0K | — |
| Q4 25 | $-23.0M | $-37.8M | ||
| Q3 25 | $-10.9M | $-28.3M | ||
| Q2 25 | $-9.7M | $-84.2M | ||
| Q1 25 | $-6.7M | $-143.0M | ||
| Q4 24 | $-33.5M | — | ||
| Q3 24 | $-13.5M | $-2.2M | ||
| Q2 24 | $-4.5M | — | ||
| Q1 24 | $-9.1M | — |
| Q4 25 | 42.5% | -1315.8% | ||
| Q3 25 | 53.5% | -676.6% | ||
| Q2 25 | 67.6% | -501.1% | ||
| Q1 25 | 62.0% | 17.9% | ||
| Q4 24 | 40.0% | — | ||
| Q3 24 | 43.5% | -145.1% | ||
| Q2 24 | 48.1% | — | ||
| Q1 24 | 25.6% | — |
| Q4 25 | -2057.5% | -3859.1% | ||
| Q3 25 | -4249.2% | -5469.1% | ||
| Q2 25 | -1900.0% | -29952.5% | ||
| Q1 25 | -318.0% | -116606.3% | ||
| Q4 24 | -2262.9% | — | ||
| Q3 24 | -11752.2% | -4313.6% | ||
| Q2 24 | -4453.8% | — | ||
| Q1 24 | -5265.3% | — |
| Q4 25 | -2015.4% | -4593.8% | ||
| Q3 25 | -4174.6% | -5305.6% | ||
| Q2 25 | -1880.7% | -17694.7% | ||
| Q1 25 | -312.0% | -63837.9% | ||
| Q4 24 | -2255.1% | — | ||
| Q3 24 | -11733.0% | -697.5% | ||
| Q2 24 | -4355.8% | — | ||
| Q1 24 | -5186.9% | — |
| Q4 25 | $-0.75 | $-0.18 | ||
| Q3 25 | $-0.34 | $-0.51 | ||
| Q2 25 | $-0.30 | $-1.60 | ||
| Q1 25 | $-0.26 | $-3.10 | ||
| Q4 24 | $-2.19 | — | ||
| Q3 24 | $-0.98 | $-0.94 | ||
| Q2 24 | $-0.36 | — | ||
| Q1 24 | $-1.13 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.6M | $60.4M |
| Total DebtLower is stronger | — | $8.3M |
| Stockholders' EquityBook value | $-31.5M | $204.2M |
| Total Assets | $25.8M | $599.2M |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.6M | $60.4M | ||
| Q3 25 | $18.7M | $9.1M | ||
| Q2 25 | $24.3M | $7.0M | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $8.6M | — | ||
| Q3 24 | $3.4M | — | ||
| Q2 24 | $9.3M | — | ||
| Q1 24 | $5.6M | — |
| Q4 25 | — | $8.3M | ||
| Q3 25 | — | $29.5M | ||
| Q2 25 | — | $16.8M | ||
| Q1 25 | — | $12.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $14.9M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-31.5M | $204.2M | ||
| Q3 25 | $-9.2M | $190.8M | ||
| Q2 25 | $1.1M | $218.6M | ||
| Q1 25 | $10.2M | $261.5M | ||
| Q4 24 | $-12.3M | — | ||
| Q3 24 | $9.7M | $-22.3M | ||
| Q2 24 | $22.7M | — | ||
| Q1 24 | $11.6M | — |
| Q4 25 | $25.8M | $599.2M | ||
| Q3 25 | $43.9M | $556.5M | ||
| Q2 25 | $50.5M | $556.0M | ||
| Q1 25 | $60.4M | $660.4M | ||
| Q4 24 | $35.1M | — | ||
| Q3 24 | $70.2M | $55.7M | ||
| Q2 24 | $74.7M | — | ||
| Q1 24 | $71.0M | — |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.5M | $-80.7M |
| Free Cash FlowOCF − Capex | $-7.0M | $-82.1M |
| FCF MarginFCF / Revenue | -616.7% | -9987.8% |
| Capex IntensityCapex / Revenue | 129.9% | 172.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-25.4M | $-139.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.5M | $-80.7M | ||
| Q3 25 | $-4.5M | $-19.6M | ||
| Q2 25 | $-6.3M | $-22.1M | ||
| Q1 25 | $-5.9M | $-14.7M | ||
| Q4 24 | $-5.4M | — | ||
| Q3 24 | $-5.5M | — | ||
| Q2 24 | $-6.0M | — | ||
| Q1 24 | $-3.8M | — |
| Q4 25 | $-7.0M | $-82.1M | ||
| Q3 25 | $-5.6M | $-20.0M | ||
| Q2 25 | $-6.6M | $-22.1M | ||
| Q1 25 | $-6.2M | $-15.6M | ||
| Q4 24 | $-5.6M | — | ||
| Q3 24 | $-5.6M | — | ||
| Q2 24 | $-6.2M | — | ||
| Q1 24 | $-3.9M | — |
| Q4 25 | -616.7% | -9987.8% | ||
| Q3 25 | -2135.4% | -3747.8% | ||
| Q2 25 | -1279.5% | -4637.2% | ||
| Q1 25 | -288.4% | -6970.1% | ||
| Q4 24 | -374.5% | — | ||
| Q3 24 | -4884.3% | — | ||
| Q2 24 | -5931.7% | — | ||
| Q1 24 | -2189.8% | — |
| Q4 25 | 129.9% | 172.4% | ||
| Q3 25 | 403.8% | 82.2% | ||
| Q2 25 | 67.4% | 3.2% | ||
| Q1 25 | 14.4% | 409.4% | ||
| Q4 24 | 14.4% | — | ||
| Q3 24 | 75.7% | — | ||
| Q2 24 | 183.7% | — | ||
| Q1 24 | 13.6% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
